Names | |
---|---|
IUPAC name
2-Acetamidopentanedioic acid
[1]
| |
Other names
Acetylglutamic acid[
citation needed]
| |
Identifiers | |
3D model (
JSmol)
|
|
3DMet | |
Abbreviations |
|
1727473 S | |
ChEBI | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.024.899 |
EC Number |
|
KEGG | |
MeSH | N-acetylglutamate |
PubChem
CID
|
|
RTECS number |
|
UNII | |
| |
| |
Properties | |
C7H11NO5 | |
Molar mass | 189.167 g·mol−1 |
Appearance | White crystals |
Density | 1 g mL−1 |
Melting point | 191 to 194 °C (376 to 381 °F; 464 to 467 K) |
36 g L−1 | |
Hazards | |
Lethal dose or concentration (LD, LC): | |
LD50 (
median dose)
|
>7 g kg−1 (oral, rat) |
Related compounds | |
Related alkanoic acids
|
|
Related compounds
|
|
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
N-Acetylglutamic acid (also referred to as N-acetylglutamate, abbreviated NAG, chemical formula C7H11NO5) [2] is biosynthesized from glutamate and acetylornithine by ornithine acetyltransferase, and from glutamic acid and acetyl-CoA by the enzyme N-acetylglutamate synthase. The reverse reaction, hydrolysis of the acetyl group, is catalyzed by a specific hydrolase. It is the first intermediate involved in the biosynthesis of arginine in prokaryotes and simple eukaryotes and a regulator in the process known as the urea cycle that converts toxic ammonia to urea for excretion from the body in vertebrates.
N-Acetylglutamic acid is an extracellular metabolite isolated from the prokaryote Rhizobium trifolii that was characterized using many structure determination techniques such as proton nuclear magnetic resonance (1H NMR) spectroscopy, Fourier-transform infrared spectroscopy, and gas chromatography-mass spectrometry.
In Rhizobium, extracellular build-up of N-acetylglutamic acid is due to metabolism involving nod factor genes on a symbiotic plasmid. When the nod factors are mutated, less N-acetylglutamic acid is produced. [3]
In prokaryotes and simple eukaryotes, N-acetylglutamic acid can be produced by N-acetylglutamate synthase (NAGS) or ornithine acetyltransferase (OAT).
OAT synthesizes N-acetylglutamic acid from glutamate and acetylornithine and is the method of choice for production in prokaryotes that have the ability to synthesize the compound ornithine. [4]
N-Acetylglutamate synthase is an enzyme that serves as a replenisher of N-acetylglutamic acid to supplement any N-acetylglutamic acid lost by the cell through mitosis or degradation. NAGS synthesizes N-acetylglutamic acid by catalyzing the addition of an acetyl group from acetyl-coenzyme A to glutamate. In prokaryotes with non-cyclic ornithine production, NAGS is the sole method of N-acetylglutamic acid synthesis and is inhibited by arginine. [4] Acetylation of glutamate is thought to prevent glutamate from being used by proline biosynthesis. [5]
In contrast to prokaryotes, NAGS in mammals is enhanced by arginine, along with protamines. It is inhibited by N-acetylglutamic acid and its analogues (other N-acetylated compounds). [4]
The brain also contains N-acetylglutamic acid at trace amounts, however no expression of NAGS is found. This suggests that N-acetylglutamic acid is produced by another enzyme in the brain that is yet to be determined. [4]
In vertebrae and mammals, N-acetylglutamic acid is the allosteric activator molecule to mitochondrial carbamyl phosphate synthetase I (CPSI) which is the first enzyme in the urea cycle. [6] It triggers the production of the first urea cycle intermediate, carbamyl phosphate. CPSI is inactive when N-acetylglutamic acid is not present. In the liver and small intestines, N-acetylglutamic acid-dependent CPSI produces citrulline, the second intermediate in the urea cycle. Liver cell distribution of N-acetylglutamic acid is highest in the mitochondria at 56% of total N-acetylglutamic acid availability, 24% in the nucleus, and the remaining 20% in the cytosol. Aminoacylase I in liver and kidney cells degrades N-acetylglutamic acid to glutamate and acetate. [7] In contrast, N-acetylglutamic acid is not the allosteric cofactor to carbamyl phosphate synthetase found in the cytoplasm, which is involved in pyrimidine synthesis. [8]
N-acetylglutamic acid concentrations increase when protein consumption increases due to the accumulation of ammonia that must be secreted through the urea cycle, which supports the role of N-acetylglutamic acid as the cofactor for CPSI. Furthermore, N-acetylglutamic acid can be found in many commonly consumed foods such as soy, corn, and coffee, with cocoa powder containing a notably high concentration. [9]
Deficiency in N-acetylglutamic acid in humans is an autosomal recessive disorder that results in blockage of urea production which ultimately increases the concentration of ammonia in the blood ( hyperammonemia). Deficiency can be caused by defects in the NAGS coding gene or by deficiencies in the precursors essential for synthesis. [4]
N-Acetylglutamic acid is the second intermediate in the arginine production pathway in Escherichia coli and is produced via NAGS. [5] In this pathway, N-acetylglutamic acid kinase (NAGK) catalyzes the phosphorylation of the gamma (third) carboxyl group of N-acetylglutamic acid using the phosphate produced by hydrolysis of adenosine triphosphate (ATP). [10]
Rhizobium can form a symbiotic relationship with white clover seedling roots and form colonies. The extracellular N-acetylglutamic acid produced by these bacteria have three morphological effects on the white clover seedling roots: branching of root hairs, swelling of root tips, and increase in the number of cell divisions in undifferentiated cells found on the outer-most cell layer of the root. This suggests that N-acetylglutamic acid is involved in the stimulation of mitosis. The same effects were observed on the strawberry clover, but not in legumes. The effects of N-acetylglutamic acid on the clover species were more potent than the effects from glutamine, glutamate, arginine, or ammonia. [4]
N-Acetylglutamic acid is composed of two carboxylic acid groups and an amide group protruding from the second carbon. The structure of N-acetylglutamic acid at physiological pH (7.4) has all carboxyl groups deprotonated.
The molecular structure of N-acetylglutamic acid was determined using proton NMR spectroscopy. [3] Proton NMR reveals the presence and functional group location of protons based on chemical shifts recorded on the spectrum. [11]
Like proton NMR, carbon-13 (13C) NMR spectroscopy is a method used in molecular structure determination. 13C NMR reveals the types of carbons present in a molecule based on chemical shifts that correspond to certain functional groups. N-Acetylglutamic acid exhibits carbonyl carbons most distinctly due to the three carbonyl-containing substituents. [12]